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Highlights: 
 This is the first study to carry out such a comprehensive intervention, 
which including strategies against stigma and discrimination, in 
community in Guangzhou, China. 
 Anticipated discrimination was significantly reduced after 9 months 
comprehensive intervention. 
 Patients learned more skills overcoming stigma, which may play an 
important role in the anti-stigma procession. 
 
Abstract  
Comprehensive interventions, including components of stigma and discrimination 
reduction in schizophrenia in low- and middle-income countries (LMICs) are lacking. 
We developed a community-based comprehensive intervention to evaluate its effects 
on clinical symptoms, social functioning, internalized stigma and discrimination among 
patients with schizophrenia. A randomized controlled trial including an intervention 
group (n=169) and a control group (n=158) was performed. The intervention group 
received comprehensive intervention (strategies against stigma and discrimination, 
psycho-education, social skills training and cognitive behavioral therapy) and the 
control group received face to face interview. Both lasted for nine months. Participants 
were measured at baseline, 6 months and 9 months using the Internalized Stigma of 
Mental Illness scale (ISMI), Discrimination and Stigma Scale (DISC-12), Global 
Assessment of Functioning (GAF), Schizophrenia Quality of Life Scale (SQLS), Self-
Esteem Scale (SES), Brief Psychiatric Rating Scale (BPRS) and PANSS negative 
scale (PANSS-N). Insight and medication compliance were evaluated by senior 
psychiatrists. Data were analyzed by descriptive statistics, t-test, chi-square test or 
Fisher’s exact test. Linear Mixed Models were used to show intervention effectiveness 
on scales. General Linear Mixed Models with multinomial logistic link function were 
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used to assess the effectiveness on medication compliance and insight. We found a 
significant reduction on anticipated discrimination, BPRS and PANSS-N total scores, 
and an elevation on overcoming stigma and GAF in the intervention group after 9 
months. These suggested the intervention may be effective in reducing anticipated 
discrimination, increasing skills overcoming stigma as well as improving clinical 
symptoms and social functioning in Chinese patients with schizophrenia. 
Key words: Schizophrenia; Stigma and Discrimination; Community; psychosocial 
interventions; Low-and middle-income countries 
 
 
 
1. Introduction  
Schizophrenia is a complex mental illness (Jablensky, 2000; Prince et al., 2007) 
affecting millions of people (Bloomfield et al., 2016) and also is one of the conditions 
associated with the highest economic burden of health care in the world (Howes and 
Murray, 2014). Though numerous studies have demonstrated the effectiveness of anti-
psychotic medications in controlling positive symptoms (Patel et al., 2007), it is difficult 
for medication treatments to remit negative symptoms and cognitive impairment 
effectively, which are correlated with social functioning. Therefore treatment with 
medication alone is insufficient to promote the rehabilitation of patients with 
schizophrenia. Treatments for this population should combine medication with 
psychosocial interventions (Asher et al., 2017). Nowadays, it is recommended a 
balanced care model between hospital and community, which can provide better 
mental health services. However, there are several challenges occurred during the 
delivery of community mental health services, stigma and discrimination have been 
proved to be an important risk factor in community mental health (Thornicroft et al., 
2016a). It is well known that people with schizophrenia often experience high levels of 
stigma and discrimination (Harangozo et al., 2014; Rose et al., 2011; Thornicroft et al., 
2009), which often lead to negative consequences, such as poor access to mental and 
physical health care (Corrigan et al., 2014), low self-esteem, social withdrawal, help-
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seeking of mental health obstacles (Brohan et al., 2011; Schomerus and Angermeyer, 
2008), high rates of unemployment, poverty, suicide and homelessness (Dereje et al., 
2012; Link and Phelan, 2006), low literacy and premature death (Thornicroft et al., 
2016b). These aspects of stigmatisation are sometimes described by people with 
schizophrenia as worse than the primary condition. 
Programs breaking down stigma and discrimination have been running for several 
years in Western high-income countries (HICs) (Corker et al., 2016; Henderson and 
Thornicroft, 2009; Knaak and Patten, 2016; Stuart, 2008; Thornicroft et al., 2014), to 
assert that people with mental disorders should be treated without stigmatization and 
discrimination (Saxena et al., 2013). Research evidence suggests that approaches 
aiming to improve mental health related knowledge and modify the negative attitudes 
and behaviors could effectively reduce stigma (Link, 2001; Pinfold et al., 2003; 
Thornicroft et al., 2007). However, most of the previous studies are from HICs 
(Thornicroft et al., 2016b) and studies in low-and middle-income countries (LMICs) 
remain few. It is necessary to integrate strategies against stigma and discrimination 
into the community mental health services. Hence, a comprehensive intervention 
aiming at decreasing clinical symptoms, improving social functioning and reducing 
stigma and discrimination is desired for patients with schizophrenia who living in 
community. 
Psycho-education is an important approach to educate people with mental health 
knowledge and erase the misconceptions about mental illness. In China, one of the 
groups of LMICs, there is a rich literature on the effectiveness of psycho-education in 
improving general psychopathology and social functioning among people with 
schizophrenia and their families and relatives (Chien and Thompson, 2014; Ran et al., 
2003; Xiang et al., 1994; Xiong et al., 1994; Zhang and Yan, 1993). Cognitive 
behavioral therapy (CBT) and social skills training (SST) have also been proved to be 
indispensable ingredients in comprehensive interventions. CBT focuses on reframing 
psychotic ideas and rebuilding healthy beliefs in the mind of people with schizophrenia 
(Sarin and Wallin, 2013; Wykes et al., 2008). SST could increase the skills solving 
problems, improve communication abilities and enhance self-management capabilities 
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(Kang et al., 2016).  
A new community model for mental health named SASD (strategies against 
stigma and discrimination) is supplied by the first author who is expert in community 
psychiatry and cultural psychiatry. The goals of SASD are to rebuild self-confidence, 
improve self-esteem, learn self-acceptance and increase skills combating stigma and 
discrimination. To our knowledge, this should be the first study to carry out such a 
comprehensive intervention in community in Guangzhou, China. Our hypothesis is that 
after the comprehensive intervention, we would see a reduction on stigma and 
discrimination, as well as an improvement on social functioning and clinical symptoms 
in patients with schizophrenia. 
 
2. Methods  
2.1. Study design and participants 
Guangzhou is the capital city of Guangdong province, comprising nearly 8 million 
registered people with an adjusted lifetime prevalence rate of mental disorders of about 
15.8% (Zhao et al., 2009). More than 20,000 of 50,000 people who have been 
registered in the system of Guangzhou severe mental disorders management 
database were diagnosed as having schizophrenia. The current study was conducted 
at Guangzhou Huiai Hospital. We used a stratified cluster random sampling in this 
study. According to the geographical locations, the 12 administrative regions in 
Guangzhou City were divided into 2 clusters (6 central districts and 6 suburban 
districts). Then we randomly selected two central districts (Tianhe and Liwan) and two 
suburban districts (Huadu and Nansha) from the 2 clusters (Li et al., 2017). Finally, we 
randomly divided the four districts into two groups: the control group (Liwan and Huadu) 
and the intervention group (Tianhe and Nansha), so each group contained a central 
district and a suburban district. The sample size was calculated by the formula in our 
previous published paper (Li et al., 2015a), assuming a 10% drop-out rate and a 
significance level of 5% (two sided) and a power of 80%, then 120 participants from 
each district were randomly recruited.  
Participants were included if they: (1) were diagnosed as having schizophrenia 
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according to ICD-10; (2) were aged between 18 and 50 years old; (3) finished primary 
school education; (4) took anti-psychotic medications with clinical stability; and (5) lived 
in the local community during the study. Participants were excluded if they: (1) had 
substance abuse, acute risk of suicide and violence; (2) were unable to understand 
and fill out the scales and questionnaires; (3) comorbid other serious physical disease, 
such as cerebrovascular diseases; and (4) were pregnant and / or lactating.  
A total of 199 participants were enrolled in the intervention group (109 in Tianhe 
and 90 in Nansha) and a total of 185 participants were enrolled in the control group 
(100 in Liwan and 85 in Huadu) at baseline. Most participants were excluded because 
of the deterioration, being lost to interview (e.g. moving) or refusing to continue the 
intervention. The details were shown in Fig1. Written informed consent was obtained 
from the participants after the procedure had been fully explained. 
 
(Figure 1 about here) 
 
Participants in the control group were provided with the face to face interview, which 
was delivered by the community psychiatrists or general practitioners. The main details 
contained the assessments of mental state, especially the psychopathological 
symptoms; daily life; situation of taking medications; and social activities. Participants 
in the intervention group received the comprehensive intervention, which was 
delivered by two experienced psychiatrists, one psychotherapist and a social worker.  
The main intervention contents included SASD, psycho-education, SST and CBT. 
Table 1 could differentiate the elements of the intervention, and show how the 
intervention modalities combined. Both groups received anti-psychotics as usual and 
operated for an equal amount of time (nine months). Because of the human resource 
limitations, the intervention was delivered eight times in total: monthly in the first six 
months and twice in the last three months. Twenty-four modules were included in the 
comprehensive intervention, and completed in eight phases. Three modules (every 
modality with one module) were given during every phase for 120 minutes. Participants 
attending every phase of this intervention were recorded and some intervention sites 
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were also taken photos when the participants agreed to do these.  
There was a manual for the comprehensive intervention, which was formulated 
according to the manual of WHO Mental Health Gap Action Program (mhGAP), and a 
series of relative books, such as Mental Health Gap Action Program Intervention Guide 
(WHO, 2010), Schizophrenia Guideline in China (Shu, 2007), Social Training for 
Schizophrenia-a-step-by-step Guide (Bellack et al., 2004), Schizophrenia 
Rehabilitation Instruction Manual in China (Wong, 2009), CBT Skills Workbook: 
Practical Exercises and Worksheets to Promote Change (Gregory, 2010) and 
Understanding the Stigma of Mental Illness: Theory and Interventions (Julio, 2008). 
The manual also considered a series of practices coping with stigma and discrimination 
around the world (Corrigan and Watson, 2002; Lasalvia et al., 2013; Link et al., 2004). 
PowerPoint slides were fabricated during the process.  
2.2. Interventions 
Strategies against stigma and discrimination (SASD): The main contents were 
approximately as follows: Introduction about the background of stigma, consequences 
of stigma, strategies against stigma and related practice training. All these were aimed 
at helping patients to accept this illness and taking a positive attitude to cope with the 
residual symptoms; rebuilding their self-confidence, strengthening their legal 
knowledge, educating patients that they had the rights in education, matrimony, 
employment, etc; helping patients to improve self-esteem to believe that they could 
make contribution to the society; practicing patients with the social skills and learning 
skills to build relationship with others. All these strategies were contributed to helping 
patients increase social interaction. This step was executed by an experienced 
psychiatrist, who had experienced the training.    
Psycho-education: The psycho-education for patients with schizophrenia 
consisted of seven modules: Introduction about the concepts of schizophrenia; 
Medication treatment of schizophrenia; Side-effects of antipsychotic drugs; Phase 
review; Rehabilitation of schizophrenia; Preferential policy on schizophrenia in 
Guangzhou; Review Module. This step was executed by an experienced psychiatrist 
who had been trained in the intervention procedure.  
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Social skills training (SST): SST in this study included six modules: 
Rehabilitation of self-management, learning to live a healthy life; Social communication 
skills, learning to manage emotion; Vocational skills, learning to show good mental 
outlook in an interview; Medication self-management skills, learning to understand 
schizophrenia and its medication treatment and also the side effects; Self-monitoring, 
learning to assess the treatment, seeking for the useful methods to deal with the 
persistent symptoms; Reintegration to society skills, encouraging participants to join 
the social activities, to cultivate the communication skills and build a harmonious 
atmosphere in the community. This step was executed by the social worker and the 
psychiatrists who had experienced the unity training.  
Cognitive Behavioral Therapy (CBT): CBT was conducted mainly as three steps. 
First, built a confidential relationship with participants by listening carefully to them; 
second, educated patients the knowledge of CBT theories, such as ABC theory of 
emotion, automatic thinking and positive thinking building, meanwhile, helped the 
participants to learn cognitive and behavioral coping skills; third, focused on skills to 
solve problems, discussed the advantages and disadvantages of medication, and 
learned methods to identify and cope with the warning signs. Homework was assigned 
after each module to help patients consolidate what they had learned during the 
therapy. Trainers had to do a review before a new module to ensure that patients had 
mastered the skills learned in previous modules. This step was carried out by the 
psychiatrists and the psychotherapist who had experienced the unity training. 
2.3. Measurements 
Internalized Stigma of Mental Illness scale (ISMI): we used the Chinese version 
of ISMI, which has good validity and reliability to assess participants’ experience of 
internalized stigma. This is a self-administered scale including 29 items and uses a 
Likert scale from 1=strongly disagree to 4=strongly agree. A higher ISMI score 
represents higher internalized stigma (Li et al., 2009). 
Discrimination and Stigma Scale (DISC-12): we used the Chinese version of 
DISC-12, which has good validity and test-retest reliability to assess participants' 
experiences of stigma and discrimination on work, relationships, parenting, housing, 
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social organizations, leisure, and religious activities during the past 12 months. The 
scale consists of four subscales (Brohan et al., 2013): experienced discrimination, 
which including 21 items, a higher score indicates greater experienced discrimination; 
anticipated discrimination, which including 4 items, a higher score indicates greater 
limitation in their daily life; overcoming stigma, which including 2 items, a higher score 
indicates knowing more strategies to overcome discrimination; positive treatment, 
which including 5 items, a higher positive treatment score indicates more positive 
treatment being reported. For further information about this Chinese version of DISC-
12 see Li et al (2016).  
Global Assessment of Functioning (GAF): we used the Chinese version of GAF, 
which has good validity and the reliability to assess psychological, social and 
occupational functioning in schizophrenia. This is an interview-administered 
questionnaire with a single-item rating from 0 to 100. A higher score represents better 
psychological, social and occupational functioning (Zhang, 1984). 
Schizophrenia Quality of Life Scale (SQLS): we used the Chinese version of 
SQLS, which has good validity and reliability to assess participants’ quality of life. This 
is a self-administered scale including 30 items. All items are scored on a 5-point Likert 
scale (0= never, 1= rarely, 2= sometimes, 3= often, and 4= always) except four items 
are reverse-coded. A lower score represents a better quality of life, while a higher score 
indicates a poorer quality of life (Li et al., 2003). 
Self-Esteem Scale (SES): we used the Chinese version of SES, which has good 
validity and reliability to indicate the degree of participants’ agreement or disagreement 
with statements about their self-esteem and self-deprecation. This is a self-
administered scale. A higher score indicates a lower self-esteem (Wang et al., 1998). 
Brief Psychiatric Rating Scale (BPRS): we used the Chinese version of BPRS, 
which has been frequently used and has good validity and reliability to assess the 
severity and change of psychotic symptoms in patients with schizophrenia. This is an 
interview-administered scale with 18 items. A higher total score represents more 
severe psychotic symptoms experienced by the participants (Zhang et al., 1983). 
Positive and Negative Syndrome Scale for Schizophrenia (PANSS): we used 
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the Chinese version of PANSS negative scale (PANSS-N), which has been frequently 
used and has good validity and reliability to assess the severity and change of negative 
symptoms in patients with schizophrenia. This study only used the negative syndrome 
subscale. The main reason was that PANSS-N was associated with the social function, 
and PANSS-N could increase the sensitivity to analysis negative symptoms. Another 
reason was the time needed and burden for participants to complete all scales. This is 
an interview-administered scale with 7 items relating to negative symptoms. A higher 
total score represents more serious negative symptoms. (Si et al., 2004). 
Insight and medication compliance assessment: Insight and medication 
compliance were assessed by senior psychiatrists. Both insight and medication 
compliance assessment were ranked from one to three. The severity of insight was 
rated as 1 (no insight), 2 (part insight) and 3 (complete insight). The severity of 
medication compliance rated as 1 (complete medication compliance), 2 (part 
medication compliance) and 3 (extremely no medication compliance).The proportion 
of every grade was calculated to assess the situation of insight and medication 
compliance in patients with schizophrenia.  
2.4. Procedure 
The trial was conducted from April, 2015 to April, 2016. The study protocol was 
approved by Research Ethics Committee of Guangzhou Huiai Hospital (Number 012, 
2015). This study was registered as a Randomized Controlled Trial, number ChiCTR-
IPR-15006246. The interviewers (two experienced psychiatrists, one psychotherapist 
and a social worker) received one day of intensive training on how to do the 
implementation of this intervention. The raters (three experienced psychiatrists, one 
psychotherapist and one psychological consultant) were also trained in another day to 
ensure the inter-rater reliability during the whole assessment. Both interviewers and 
raters were trained by the research conductor (the first author) who was experienced 
in illustrating the PowerPoint slides and conducting these scales and questionnaires. 
They were also supervised by the research conductor during the whole trial. All 
modules were conducted at the participants’ local community health service center.  
2.5. Data collection 
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Data were collected at 3 points: 1) baseline: pre-intervention; 2) 6 months: mid-
intervention; and 3) 9 months: end-intervention. BPRS, PANSS-N, GAF, insight and 
medication compliance were completed by three experienced psychiatrists via face to 
face interview. DISC-12 was completed by one psychotherapist and one psychological 
consultant via reading the items to the participants and participants showed them the 
answers. ISMI, SQLS and SES were completed by the participants themselves.  
2.6. Statistical Analysis 
All statistical analyses were performed using IBM SPSS Statistics 20.0 (IBM 
Corporation, USA). Descriptive statistics, including the mean, standard deviation (SD), 
frequency, and proportion were used to describe the demographics and the outcomes 
of study participants at baseline, 6 months and 9 months (the primary endpoint). 
Differences between the participants’ demographics by interventions were assessed 
by the t-test for continuous variables or the chi-square test or Fisher’s exact test for 
categorical variables. 
The analyses of outcomes were based on the intention to treat principle. Linear 
Mixed Models were used to show intervention effectiveness on BPRS, PANSS-N, GAF, 
SQLS, SES, ISMI, DISC-12 subscales. General Linear Mixed Models with multinomial 
logistic link function were used to assess the effectiveness on medication compliance 
and insight. Regression coefficients (b) or odds ratio (OR) with 95% confidence 
intervals (CI), and intra-class correlation (ICC) resulting from clusters (districts) were 
calculated. Participants’ demographics were not adjusted because there were no 
significant differences between intervention and control groups. All statistical tests 
were two-tailed with a significance level of 0.05.   
 
3. Results  
3.1. Recruitment and sample characteristics 
A total of 199 participants were recruited to the intervention group and 185 to the 
control group at baseline. At 6 months, 169 participants (85%) in the intervention group 
and 158 participants (85%) in the control group completed the intervention. At 9 
months, 169 participants (85%) in the intervention group and 154 participants (83%) 
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in the control group completed the intervention. The results of the chi-square test 
revealed that there was no significant difference between the two groups at the three 
time points (p=0.985). Non-participation was mainly the results of deterioration, lost or 
refusal (see CONSORT chart at Fig.1). The final analyses of outcomes were based on 
the intention to treat principle.  
(Figure 1 about here) 
Table 2 and Table 3 showed the demographic and clinical characteristics of the 
intervention group and control group at baseline. There were no significant differences 
in age, gender, years of education, race, marital status, occupations, number of 
hospitalizations and duration of illness. However, participants in the intervention group 
had significantly lower scores in BPRS and PANSS-N scales than those in the control 
group at baseline (p<0.05), apart from the two variables, the two groups were well 
matched and there were no significant differences identified in other baseline clinical 
characteristics (p>0.05). 
 
(Tables 2 and 3 about here) 
 
3.2. Outcomes at 6 months and 9 months  
Participants’ psychological and clinical changes were measured at 6 months and 
9 months with the following scales: ISMI, DISC-12, GAF, SQLS, SES, BPRS and 
PANSS-N. Baseline differences in BPRS and PANSS-N scores were controlled when 
examining any of the outcomes. Table 3 showed the changes of the two groups at the 
two time points.  
 
(Table 3 about here) 
 
3.2.1. Changes in stigma and discrimination    
As shown in Table 3, there was no statistically significant reduction on ISMI total 
scores in the intervention group when compared with the control group after 9 months 
intervention (p=0.440). However, some primary outcomes in DISC-12 subscales were 
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noteworthy. We noted a significant elevation in the subscale of overcoming stigma in 
the intervention group when compared with the control group after the intervention and 
there was a significant interaction between intervention and time (95%CI 0.18 to 0.67, 
p=0.001). At 6 months and 9 months, mean scores of overcoming stigma in 
intervention group were significantly higher than the control group (both p<0.001). 
What’s more, the anticipated discrimination score in the intervention group was 
significantly lower than the control group after 9 months intervention and there was a 
significant interaction between intervention and time (95%CI -0.59 to -0.01, p=0.046).  
There was no significant difference by the end of the intervention on experienced 
discrimination in the intervention group when compared with the control group after 9 
months intervention (p>0.05). At 9 months, though the t-test result showed there was 
a significant decrease on positive treatment in the intervention group when compared 
with the control group (p=0.04), Linear mixed model showed that there was no 
significant difference by the end of the intervention on positive treatment comparing 
the two groups (p>0.05). Details were shown in Fig.2-3 and Table 3. 
 
(Figure 2-3 about here) 
 
3.2.2. Changes in functioning and quality of life   
As shown in Table 3 and Fig.4, GAF total score in intervention group was 
significantly higher than the control group after the intervention and there was a 
significant interaction between intervention and time (95%CI 6.88 to 11.46, p<0.001). 
At 6 months and 9 months, GAF total scores in intervention group were significantly 
higher than the control group (both p<0.001). There were no significant differences on 
SQLS between the two groups after 9 months intervention (p>0.05). 
 
(Figure 4 about here) 
 
3.2.3. Changes in psychotic symptoms   
As shown in Table 3 and Fig.5, we noted that BPRS total score in the intervention 
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group was significantly lower than the control group after the intervention and there 
was a significant interaction between intervention and time (95%CI -4.92 to -2.67, 
p<0.001). At 6 months and 9 months, there was a significant reduction on BPRS total 
score in the intervention group when compared with the control group (both p<0.05), 
after adjustment for baseline BPRS total scores. At the same time, we noted that 
PANSS-N total score in intervention group was significantly lower than the control 
group at the end of the intervention and there was a significant interaction between 
intervention and time (95%CI -4.31 to -2.67, p<0.001) (Table 3 and Fig.6), after 
adjustment for baseline PANSS-N total scores. At 6 months and 9 months, there was 
a significant reduction on PANSS-N total score in the intervention group when 
compared with the control group (both p<0.05). 
 
(Figure 5 and 6 about here) 
 
3.2.4. Changes in insight and medication compliance 
In addition, we measured participants’ medication compliance and insight. We 
found there were no significantly differences on insight and medication compliance 
between the two groups at the end of the intervention (both p>0.05). Details were 
shown in Table 3. 
3.2.5. Changes in self-esteem    
What’s more, the outcome of SES showed that there was no significant difference 
between the two groups at the end of the intervention (p=0.805). At 6 months, SES 
total score in intervention group was significantly lower than the control group (p=0.01). 
Details were shown in Table 3. 
 
4. Discussion 
To our knowledge, interventions related with stigma among people with mental 
illness are still in their infancy in China (Xu et al., 2017). This is the first study to conduct 
a comprehensive intervention among patients with schizophrenia who living in 
community in Guangzhou, China and to assess its effects on clinical symptoms, social 
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functioning, internalized stigma and discrimination. Few effective programs have 
integrated with strategies against stigma and discrimination in the Chinese community 
mental health services. Generally speaking, the findings in this study indicate that the 
comprehensive intervention may be effective for people with schizophrenia, especially 
on discrimination reduction, clinical symptoms lessening and social functioning 
improvement. 
 The results of this study suggested that internalized stigma in patients with 
schizophrenia has not been reduced after this intervention program. This is similar to 
the study of Chatterjee et al (2014), who also found no additional contribution in 
reducing stigma after a community-based intervention (Chatterjee et al., 2014). Stigma 
is a complicate psycho-social issue, which can be emerged when amounts of 
components interact. Self-stigma occurs when an individual with mental illness 
internalizes the negative stereotypes, adopts prejudice and loses self-esteem and self-
efficacy. It is an internalized and consolidated performance of negative thoughts and 
experience, which is pervasive and difficult to eradicate. Interventions from one level 
or one facet could not change it effectively. Patients’ attitudes and behaviors towards 
the illness can be influenced by the family members and the public, which can hinder 
or increase difficulties for patients to fight with the internalized stigma. Hence, these 
may indicate that interventions towards the family members and the public to correct 
the misunderstandings of mental disorders and rebuild a positive thinking are 
necessary. Though there were no significant differences found between the two groups, 
we could see the reduced trend appeared in the intervention group, we assume that 
the effect of interventions against internalized stigma could be significantly improved 
when combing with strategies combating public stigma. 
We found some positive results in relation to discrimination, which may have some 
positive effects on erasing discrimination and stigma in the future. This study showed 
that the skills of overcoming stigma in the intervention group were significantly 
improved at both 6 months and 9 months, and there was a significant interaction 
between intervention and time, this suggested that the comprehensive intervention 
could educate participants to be familiar with more skills to reduce discrimination. The 
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anticipated discrimination in the intervention group was significantly lower after the 
comprehensive intervention, indicating that fewer participants stopped themselves 
from starting relationships and they would not avoid or shun others who knew they had 
mental illness.  
These results are consistent with the findings of Shin et al (2002), who found 
greater coping skills in Korean Americans with a diagnosis of schizophrenia (Shin and 
Lukens, 2002). The reasons can be explained from the contents of the comprehensive 
methods. There are eight modules in the intervention related with stigma and 
discrimination, which means SASD is educated to the patients during most of the 
interventional period, which therefore can ensure patients to contact with these 
strategies in most of their time. SASD aims at rebuilding patients’ confidence by 
encouraging them to communicate with others and training patients with skills to face 
with stigma and deal with some related problems. The effects of other three methods 
should not be ignored. At the same time the stigma reduction intervention was not 
directly based upon the principle of interpersonal contact, and so the results indicate 
that such interpersonal contact can be usefully employed in future intervention studies 
intended to reduce stigma (Thornicroft et al., 2016b) 
Psycho-education could give participants a greater understanding and knowledge 
of schizophrenia (Armijo et al., 2013). SST could improve their social functioning and 
interpersonal relations and give them hope (Yildiz et al., 2004). The format of CBT 
could attract patients to attend the program, reduce social withdraw and the regular 
contact with psychiatrists could consolidate the attitude and behavior change (Kersten 
et al., 2016). All these may contribute to reducing discrimination. Linear mixed models 
showed that there were no significant changes on the subscales of experienced 
discrimination or positive treatment. These indicated this intervention might not play a 
role on the two parameters, or its effects were influenced by the external-environment. 
Lastly, this study indicated a significant improvement in social functioning, which 
was assessed by GAF. GAF score in the intervention group was greatly increased at 
both 6 months and 9 months, and there was a significant interaction between 
intervention and time. Our results were consistent with Temple et al (2005), who found 
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an improvement of global psychosocial functioning in patients with schizophrenia 
(Temple and Ho, 2005). Pena et al (2016) also stated a similar result of social function 
in patients with schizophrenia who participated in the integrative cognitive remediation 
program (Pena et al., 2016). Some possible reasons may be that participants in this 
study not only received professional psycho-education but practiced social skills 
training. What is more, a large number of researchers have proved that the format and 
specific strategies of CBT can improve global and social functioning (Li et al., 2015b; 
Sarin and Wallin, 2013; Wykes et al., 2005).  
Another interesting finding was the significant improvement of self-esteem at 6 
months and an increased trend at 9 months though with no significant differences. This 
indicates that the intervention improves self-esteem to some extent, and may be 
because of the reduced frequency in the last three months that we do not get the 
expected results in 9 months. So a higher frequency and intensity of interventions are 
needed in future research. Furthermore, we noted a significant reduction of BPRS and 
PANSS-N scores in the intervention group after 9 months intervention, which were 
consistent with previous studies (Fujita et al., 2010; Shin and Lukens, 2002; Tempier 
et al., 2012). These findings reflect the comprehensive intervention can reduce 
psychotic symptoms, especially some negative symptoms in patients with 
schizophrenia. It’s worth noting that participants in the study have a median duration 
of about 14 years of illness and symptoms were moderate in severity. For this group 
of people with long-term and severe symptoms, these improvements in BPRS and 
PANSS-N could be viewed as important outcomes. 
In conclusion, although our intervention has no directly significant effects on self-
stigma, it still has implications for the peers for its effects on discrimination reduction, 
clinical symptoms lessening, and social functioning improvement. The frequency of the 
intervention can be more intensive in order to improve self-esteem and approaches to 
reduce self-stigma are needed to be identified.  
Strengths and limitations of the study 
Several limitations in this study should be taken into consideration. First, the 
intervention was conducted only eight times during 9 months because of the human 
AC
CE
PT
ED
 M
AN
US
CR
IPT
 18 
resource limitations. Second, all the evaluation researches have the subjective bias, 
it’s also difficult for this study to eliminate this bias. Third, there may have a synergy 
effect among the four components of this intervention. It is difficult to calculate the 
contribution of each component in this study. Further explorations are needed to 
examine the effectiveness of each intervention component. Fourth, this study only 
showed the effects of the program at the moment of intervention end-point, the 
effectiveness of the follow-up is undergoing. Fifth, the intervention to reduce stigma 
was not directly based upon the principle of inter-persona contact. Despite these 
limitations, we believe that our study also has some clear advantages. First, this study 
was under the overall guidance of the World Psychiatric Association’s Global Anti-
stigma program. Second, this is the first study about comprehensive intervention, 
which including strategies against stigma and discrimination, conducted among people 
with schizophrenia in the community in China. Third, the scales used in this study have 
good psychometric properties in their Chinese versions. 
Implications of the study 
This study suggests that the comprehensive intervention package used, (including 
SASD, psycho-education, SST and CBT) could have some positive impacts in patients 
with schizophrenia in community in Guangzhou, China, such as reduction on 
discrimination, improvement on social functioning and the clinical symptoms, 
especially the negative symptoms. However, schizophrenia may be a long-term 
condition, and a longer duration of follow-up is needed to show any additional benefits 
of the comprehensive interventions (Ran et al., 2015). What’s more, family intervention 
was included in our design originally, however, we didn’t do it in the later study, two 
reasons can explain this problem. First, because of the inconvenience of the family 
members, it’s hard for us to gather them together. Second, because of the long duration 
of this illness in the patients, family members may not show too much care on them. 
It’s indicated the importance of interventions on family members and the public. 
Additionally, the biggest challenge in this study may be the manpower for delivery of 
essential mental health interventions. “Task-shifting” is an effective approach to relieve 
the limitations of manpower, mental health specialists can via brief training and 
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appropriate supervision of non-specialist health professionals to strengthen human 
resources. In this study, participants in the control group were cared by the community 
psychiatrists or general practitioners. There was a support policy in China that general 
practitioners could achieve the license of psychiatry if they passed the psychiatric 
training, which could make up for the shortage of human resources in mental health. 
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Divided 12 administrative regions into 2 clusters according to geographic measures 
Central districts: Liwan, Yuexiu, Tianhe, Huangpu, Panyu, and Haizhu 
suburban districts: Baiyun, Huadu, Conghua, Zengcheng, Luogang, and Nansha 
 
2 central districts and 2 suburban districts were randomly selected  
(Liwan, Tianhe, Huadu and Nansha) 
 
Randomized  
Randomized  
(each group concluded a central district and a suburban district) 
Intervention group (n=240) 
(Tianhe and Nansha, each district 
randomly selected 120 participants) 
 
Control group (n=240) 
(Liwan and Huadu, each district 
randomly selected 120 participants) 
 
Excluded (n=41) 
Not meeting inclusion criteria (n=41) 
 Tianhe: 11 excluded.  
 Nansha: 30 excluded. 
Excluded (n=55) 
Not meeting inclusion criteria (n=55) 
 Liwan: 20 excluded.  
 Huadu: 35 excluded. 
199 allocated to intervention group 185 allocated to control group 
At 6 months, 169 assessed, 30 lost 
 Tianhe: 89 assessed, 20 lost 
Deterioration (n=6, 4 inpatient) 
Lost (n=3) 
Refused (n=11) 
 Nansha: 80 assessed, 10 lost 
Deterioration (n=5, 1 inpatient, 
1died) 
Refused (n=5) 
At 6 months, 158 assessed, 27 lost 
 Liwan: 85 assessed, 15 lost  
Deterioration (n=6, 2 inpatient) 
Lost (n=1) 
Refused (n=8) 
 Huadu: 73 assessed, 12 lost  
Deterioration (n=8, 5 inpatient) 
Refused (n= 4) 
At 9 months, 169 assessed, 30 lost 
 Tianhe: 86 assessed, 23 lost 
Deterioration (n=8, 2 inpatient, 2 died) 
Refused (n=15) 
 Nansha: 83 assessed, 7 lost 
Deterioration (n=3, 2 inpatient, 1 died) 
Refused (n=4) 
At 9 months, 154 assessed, 31 lost 
 Liwan: 84 assessed, 16 lost 
Deterioration (n=4,1 inpatient) 
Refused (n=12) 
 Huadu: 70 assessed, 15 lost  
Deterioration (n=4, 2 inpatient, 1 died) 
Refused (n=11) 
Fig. 1 CONSORT (Consolidated Standards of Reporting Trials) diagram. 
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Table 1 The contents of the comprehensive intervention 
 Modalities Modules and contents 
Psycho-education/SASD 
1.Introduction of the background on schizophrenia 
2.Medical treatment of schizophrenia 
3.Side-effects of antipsychotic drugs 
4.A review of the three modules before  
5.Rehabilitation of schizophrenia 
6.Preherential policy on schizophrenia in Guangzhou, China 
7.Introduction of stigma in schizophrenia 
8.A review of the modules given before 
SST/SASD 
9.Rehabilitation of self-management 
10.Social communication skills 
11.Vocational skills training 
12.Medication self-management skills 
13.Self-monitoring 
14.Reintegration to society skills 
15.Consequences of stigma and discrimination 
16.Skills against stigma and discrimination 
CBT/SASD 
17.Build a confidential relationship with patients 
18.Introduction of CBT Ⅰ: ABC theory of emotion 
19.Introduction of CBT Ⅱ: Automatic thinking 
20. Introduction of CBT Ⅲ: Build a positive thinking 
21.Correct the misunderstandings of schizophrenia 
22. Anti-stigma skills training 
23.Self-acceptance learning 
24.A review of the modules given before 
Notes: Abbreviations: SASD=strategies against stigma and discrimination. SST=social skills training, CBT=cognitive 
behavioral therapy, ABC=Antecedent, Belief, Consequence. Twenty-four modules were included in the 
comprehensive intervention, and completed in eight phases. Three modules (every modality with one module) were 
given during every phase for120 minutes. 
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Table 2 Socio-demographic characteristics (baseline) 
Characteristics 
Intervention Group 
(n=199) 
Control Group 
(n=185) 
t-value/ 
x2-value 
p-value 
Age, years: mean (SD) 40.21 (7.57) 39.70 (7.83) 0.65 0.52 
Education, years: mean (SD) 10.31 (2.51) 9.92 (2.69) 1.46 0.15 
Race (Han) n(%) 198 (99.5) 182 (98.4)  0.36 
Sex n(%)   0.70 0.40 
Male 98 (49.2) 99 (53.5)   
Female 101 (50.8) 86 (46.5)   
Marital status n(%)   3.31 0.35 
Single 103 (51.8) 95 (51.4)   
Married 76 (38.2) 70 (37.8)   
Divorce/Widowed 20 (10.1) 20 (10.8)   
Occupation n(%)   2.46 0.12 
Yes 65 (32.7) 47 (25.4)   
No 134 (67.3) 138 (74.6)   
Duration of illness, years: mean (SD) 14.11 (7.49) 15.00 (8.45) -1.09 0.28 
Number of hospitalizations , times: 
mean (SD) 
2.60 (2.50) 2.36 (3.51) 0.76 0.45 
Notes: Data were indicated by mean, standard deviation (SD), frequency and proportion. 
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Table 3 Effectiveness of the comprehensive interventions at baseline, 6-month and 9-month  
Notes: The analyses of outcomes were based on the intention to treat principle. Data were indicated by mean, standard deviation (SD), frequency and proportion. Abbreviations: ICC=intra-class correlation, ICC is 
the proportion of variance in the outcome that can be accounted for by differences among districts. BPRS=Brief Psychiatric Rating Scale. PANSS-N=PANSS negative scale. GAF=Global Assessment of Functioning. 
SQLS=Schizophrenia Quality of Life Scale. ISMI=Internalized Stigma of Mental Illness scale. SES=Self-Esteem Scale. DISC=Discrimination and Stigma Scale. #: the interaction between intervention and time was 
significant (p<0.05).
Intervention 
Intervention Group (n=169) Control Group (n=158) 
b(95%CI)/OR(95%CI) p-value ICC 
Baseline 6-month 9-month Baseline 6-month 9-month 
BPRS total score: mean (SD)# 26.60 (6.39) 22.75 (4.19) 21.92 (3.44) 28.12 (7.84) 24.65 (5.77) 25.65 (6.72) -3.79(-4.92 to -2.67) <0.001 0.2511 
PANSS-N total score : mean (SD)# 16.40 (5.28) 10.73 (3.42) 9.71 (3.06) 17.96 (5.43) 12.14 (4.23) 13.06 (4.53) -3.49(-4.31 to -2.67) <0.001 0.1248 
GAF total score : mean (SD)# 63.76 (10.59) 73.46 (10.19) 77.98 (8.91) 61.61 (12.27) 67.22 (11.88) 67.70 (10.62) 9.17(6.88 to11.46) <0.001 0.2280 
SQLS total score : mean (SD) 31.64 (15.74) 29.61 (13.54) 30.60 (14.10) 31.95 (15.97) 31.71 (16.90) 31.24 (16.00) -0.06(-3.53 to 0.65) 0.973 0.1989 
ISMI total score : mean (SD) 2.30 (0.38) 2.21 (0.40) 2.24 (0.37) 2.30 (0.40) 2.28 (0.39) 2.30 (0.39) -0.04(-0.14 to0.06) 0.440 0.1235 
DISC-12 subscales: mean (SD)          
Experienced discrimination  0.20 (0.26) 0.18 (0.23) 0.16 (0.23) 0.21 (0.29) 0.22 (0.31) 0.21 (0.29) -0.05(-0.12 to 0.03) 0.205 0.2520 
Anticipated discrimination# 0.79 (0.72) 0.51 (0.65) 0.52 (0.68) 0.79 (0.72) 0.62 (0.68) 0.84 (0.86) -0.30(-0.59 to -0.01) 0.046 0.2898 
Overcoming stigma# 0.73 (0.67) 1.16 (0.83) 1.09 (0.83) 0.78 (0.71) 0.72 (0.64) 0.63 (0.62) 0.43(0.18 to 0.67) 0.001 0.3578 
Positive treatment# 0.75 (0.66) 0.65 (0.62) 0.50 (0.45) 0.70 (0.60) 0.53 (0.56) 0.61 (0.48) -0.11(-0.30 to 0.07) 0.220 0.2298 
SES total score : mean (SD) 22.95 (3.92) 22.51 (3.68) 22.89 (3.61) 23.34 (3.88) 23.56 (3.88) 23.23 (3.77) -0.14(-1.25 to 0.97) 0.805 0.2168 
Medication compliance n (%)       0.33(0.10 to 1.15) 0.082 0.4152 
Complete compliance 155(77.9) 160(94.7) 163(95.9) 137(74.1) 138(87.3) 138(89)    
Part compliance 42(21.1) 8(4.7) 7(4.1) 46(24.9) 17(10.8) 13(8.4)    
No compliance 2(1.0) 1(0.6) 0(0.0) 2(1.0) 3(1.9) 4(2.6)    
Insight n (%)       1.39(0.90 to 2.15) 0.134 0.4723 
Complete insight 22(11.1) 80(47.3) 92(54.1) 24(13.0) 60(38.0) 70(45.2)    
Part insight 134(67.3) 85(50.30) 75(44.1) 104(56.2) 91(57.6) 74(47.7)    
No insight 43(21.6) 4(2.40) 3(1.8) 57(30.8) 7(4.4) 11(7.1)    
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Fig.2  DISC Overcoming stigma scores of the intervention group and control group by time 
point. Data were indicated by mean (standard error). ***p<0.0001 
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Fig.3  DISC Anticipated discrimination Scores of the intervention group and control group by 
time point. Data were indicated by mean (standard error). ***p<0.0001 
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Fig.4  GAF Scores of the intervention group and control group by time point. Data were indicated 
by mean (standard error). GAF=Global Assessment of Functioning. ***p<0.0001 
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Fig.5  BPRS Scores of the intervention group and control group by time point. Data were indicated 
by mean (standard error). BPRS=Brief Psychiatric Rating Scale. *p<0.05, **p<0.01, ***p<0.0001 
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Fig.6  PANSS-N Scores of the intervention group and control group by time point. Data were 
indicated by mean (standard error). PANSS-N=PANSS negative scale. **p<0.01, ***p<0.0001 
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